T1	Outcomes 280 299	efficacy and safety
T2	Outcomes 899 929	rates of retinitis progression
T3	Outcomes 1256 1352	rates of increase in retinal area involved by CMV, visual field loss, or visual acuity outcomes.
T4	Outcomes 1357 1371	mortality rate
T5	Outcomes 1487 1496	mortality
T6	Outcomes 1651 1666	mortality rates
T7	Outcomes 1830 1844	mortality rate
T8	Outcomes 1922 1936	mortality rate
T9	Outcomes 2230 2241	ineffective
T10	Outcomes 2282 2296	mortality rate
